- Home
- BQ vs CRIS Comparison
BQ vs CRIS Comparison
Compare BQ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- CRIS
- Stock Information
- Founded
- BQ 2008
- CRIS 2000
- Country
- BQ China
- CRIS United States
- Employees
- BQ N/A
- CRIS N/A
- Industry
- BQ Other Specialty Stores
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BQ Consumer Discretionary
- CRIS Health Care
- Exchange
- BQ Nasdaq
- CRIS Nasdaq
- Market Cap
- BQ 25.0M
- CRIS 22.9M
- IPO Year
- BQ 2020
- CRIS 2000
- Fundamental
- Price
- BQ $7.73
- CRIS $1.55
- Analyst Decision
- BQ
- CRIS Strong Buy
- Analyst Count
- BQ 0
- CRIS 2
- Target Price
- BQ N/A
- CRIS $16.50
- AVG Volume (30 Days)
- BQ 3.5M
- CRIS 69.9K
- Earning Date
- BQ 07-21-2025
- CRIS 11-13-2025
- Dividend Yield
- BQ N/A
- CRIS N/A
- EPS Growth
- BQ N/A
- CRIS N/A
- EPS
- BQ N/A
- CRIS N/A
- Revenue
- BQ $64,617,102.00
- CRIS $11,405,000.00
- Revenue This Year
- BQ N/A
- CRIS $2.72
- Revenue Next Year
- BQ N/A
- CRIS $8.27
- P/E Ratio
- BQ N/A
- CRIS N/A
- Revenue Growth
- BQ N/A
- CRIS 12.24
- 52 Week Low
- BQ $1.62
- CRIS $1.02
- 52 Week High
- BQ $46.70
- CRIS $5.45
- Technical
- Relative Strength Index (RSI)
- BQ 48.24
- CRIS 46.49
- Support Level
- BQ $7.71
- CRIS $1.44
- Resistance Level
- BQ $8.62
- CRIS $1.63
- Average True Range (ATR)
- BQ 4.42
- CRIS 0.10
- MACD
- BQ -0.66
- CRIS 0.00
- Stochastic Oscillator
- BQ 0.77
- CRIS 46.46
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.